Skip to main content
. 2021 Jun 3;139(7):769–776. doi: 10.1001/jamaophthalmol.2021.1660

Table 3. Validated Classification of Reasons for Treatment Nonadherence or Nonpersistence to Therapy in Neovascular Age-Related Macular Degeneration.

Classification Subcategories Mean (SD) Delphi score
Patient associated
  • Patient education level or understanding of the need for treatment

  • Patient loss of motivation

  • Ocular comorbidities

  • Nonocular comorbidities or general health problems

  • Consent withdrawal

  • Treatment burden

  • Other

9.27 (1.56)
Condition associated
  • Treatment success (patient determined)

  • Treatment failure (patient determined)

  • Treatment contraindication

  • Poor baseline visual acuity

  • Other

9.27 (1.42)
Therapy associated
  • Treatment discomfort

  • Adverse event

  • Fear of injections

  • Other

8.64 (2.34)
Health system and health care team associated
  • Administrative problem

  • Access to treatment (eg, appointment availability)

  • Distance to treatment

  • Other

8.73 (2.33)
Social/economic
  • Lack of transportation

  • Caregiver availability (eg, to attend clinic appointment with patient)

  • Direct cost or reimbursement issue

  • Indirect costs (eg, parking fees, productivity loss)

  • Other

8.82 (2.34)
Other
  • Death

  • Uncontrollable/unpredictable event (eg, restrictions or deferral of appointment because of COVID-19 pandemic)

9.64 (0.67)